Patents by Inventor Eric Saman
Eric Saman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20040005548Abstract: The invention concerns a process for diagnosis of an HIV infection by means of an immunoassay using the specific detection of the p24 antigen of HIV1, HIV1-Sub0 and/or the p26 antigen of HIV2, at least one antibody against the env region of HIV1, HIV1-Sub0 and/or of HIV2 and at least one antibody against the pol and/or gag region of HIV1, HIV1-Sub0 and/or HIV2, reagent kits and test strips suitable for diagnostic procedure as well as monoclonal antibodies against p24 and their use.Type: ApplicationFiled: April 22, 2003Publication date: January 8, 2004Applicant: Roche Diagnostics GmbHInventors: Elke Faatz, Marie-Ange Buyse, Eric Saman
-
Publication number: 20030180759Abstract: The current invention relates to new HIV-1 group O antigens, nucleic acids encoding them, and the use of said antigens and/or nucleic acids as reagents in the diagnosis and prophylaxis of AIDS. It also relates to new HIV-1 group O strains comprising these antigens.Type: ApplicationFiled: December 16, 2002Publication date: September 25, 2003Applicant: INNOGENETICS N.V.Inventors: Eric Delaporte, Martine Peeters, Eric Saman, Marleen Vanden Haesevelde
-
Patent number: 6593079Abstract: The invention concerns a process for diagnosis of an HIV infection by means of an immunoassay using the specific detection of the p24 antigen of HIV1, HIV1-Sub0 and/or the p26 antigen of HIV2, at least one antibody against the env region of HIV1, HIV1-Sub0 and/or of HIV2 and at least one antibody against the pol and/or gag region of HIV1, HIV1-Sub0 and/or HIV2, reagent kits and test strips suitable for diagnostic procedure as well as monoclonal antibodies against p24 and their use.Type: GrantFiled: January 12, 2000Date of Patent: July 15, 2003Assignee: Roche Diagnostics GmbHInventors: Frederic Donie, Elke Faatz, Barbara Upmeier, Eva Hoess, Marie-Ange Buyse, Eric Saman
-
Publication number: 20030039954Abstract: Described is a new variety of retrovirus designated HIV-3, also known as HIV-1 subtype O, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described is a process to detect the HIV-3 retrovirus in biological liquids or tissue. One such process involves contacting a biological sample suspected of containing HIV-3 nucleic acids with a DNA probe corresponding to a segment of genomic HIV-3 retrovirus RNA, such as the LTR region, and detecting the hybridization products thereof.Type: ApplicationFiled: May 9, 2001Publication date: February 27, 2003Applicant: Innogenetics N.V.Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
-
Patent number: 6511801Abstract: The claimed invention relates to an HIV-1 group O envelope antigen comprising SEQ ID NO: 100, and the use of said antigen as a reagent in the diagnosis of HIV-1 group O infection, and a kit therefore.Type: GrantFiled: April 3, 2000Date of Patent: January 28, 2003Assignee: Innogenetics, N.V.Inventors: Eric DeLaporte, Martine Peeters, Eric Saman, Marleen Vanden Haesevelde
-
Patent number: 6296855Abstract: The present invention relates to an isolated 17-kDa Brucclla antigen characterized by an amino acid sequence having at least 60% homology, preferably at least 70% homology, more preferably having at least 80% homology to the amino acid sequence as shown in SEQ ID No. 1 or 2, with said antigen being specifically recognized by sera from Brucella field infected individuals, more particulary an antigen characterized by the amino acid sequence as shown in SEQ ID No. 1 or 2. The invention also relates to recombinantly produced 17 kDa Brucella antigen, nucleic acids coding for the same and the use thereof in diagnostic and prophylactic methods and kits.Type: GrantFiled: December 1, 1997Date of Patent: October 2, 2001Assignee: Innogenetics N.V.Inventors: Fabienne Hemmen, Eric Saman
-
Patent number: 6265200Abstract: Described is a new variety of retrovirus designated HIV-3, also known as HIV-1 subtype O, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are variants of the virus.Type: GrantFiled: August 23, 1999Date of Patent: July 24, 2001Assignee: Innogenetics N.V.Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
-
Patent number: 6172192Abstract: The present invention relates to isolated and pure Toxoplasma gondii antigenic fragments, recombinant polypeptides, nucleic acids encoding them, primers and probes derived from the same, as well as the use of these polypeptides, nucleic acids, primers and probes in methods and kits for the diagnosis and prevention of T. gondii infection in mammals (humans and animals).Type: GrantFiled: June 30, 1998Date of Patent: January 9, 2001Assignee: Innogenetics N.V.Inventors: Dirk Jacobs, Eric Saman, Hugo Van Heuverswyn
-
Patent number: 6013484Abstract: Described is a new variety of retrovirus designated HIV-3, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.Type: GrantFiled: July 25, 1997Date of Patent: January 11, 2000Assignee: Innogenetics N.V.Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
-
Patent number: 5858647Abstract: Described is a new variety of retrovirus designated HIV-3, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. The methods to detect antibodies against HIV-3 retrovirus in a biological fluid involve contacting the suspect body fluid with a composition containing one or more of the proteins or glycoproteins of HIV-3 or with a lysate of the virus, or with an antigen possessing epitopes common to HIV-3, and detecting the immunological conjugate formed between the anti-HIV-3 antibodies and the antigen(s) used.Type: GrantFiled: June 7, 1995Date of Patent: January 12, 1999Assignee: Innogenetics N.V.Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
-
Patent number: 5795743Abstract: Described is a new variety of retrovirus designated HIV-3 samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.Type: GrantFiled: June 7, 1995Date of Patent: August 18, 1998Assignee: Innogenetics N.V.Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
-
Patent number: 5567603Abstract: Described is a new retrovirus designated HIV-3, samples of which have been deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301.Type: GrantFiled: April 15, 1994Date of Patent: October 22, 1996Assignee: Innogenetics N.V.Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
-
Patent number: 5304466Abstract: Described is a new retrovirus designated HIV-3 and deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.Type: GrantFiled: March 23, 1990Date of Patent: April 19, 1994Assignee: Innogenetics N.V.Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, H. Van Heuverswyn